Investors can expect the Dow Jones Today to remain steady.
But a stable tech sector will offset uncertain Brexit developments and the latest news on Dow component Boeing Co. (NYSE: BA).
Investors can expect the Dow Jones Today to remain steady.
But a stable tech sector will offset uncertain Brexit developments and the latest news on Dow component Boeing Co. (NYSE: BA).
Recreational marijuana legalization got a lot of media ink in 2018 – for good reason.
But a separate cannabis market focused on healing, medicinal uses, and wellness is also exploding.
That's making marijuana stocks one of the hottest investment opportunities we've seen in years...
The Dow Jones today will hold steady as investors await developments on a trade deal between the U.S. and China. Meanwhile, the market is gearing up for Friday's official monthly report from the U.S. Labor Department.
For investors who thought 2018 was the best year yet for cannabis stocks, 2019 is already off to an even better start. This will be by far the best year yet for marijuana stocks, thanks to one exceptional catalyst.
Pot stocks in 2019 will be propelled by CBD. That's an acronym for cannabidiol. It's one of the multiple chemical compounds in marijuana.
The cannabis market is expected to grow close to $150 billion by 2025.
New applications for CBD continue to be found: skin moisturizers, honey, coffee, beer, nutrition bars, gummies, energy shots, and more.
The Dow Jones today is projecting a 210-point gain on news that U.S. lawmakers have drafted an agreement that could prevent another government shutdown from coming this week.
While that's great news for stocks, an agreement with China would be an even bigger catalyst.
Thankfully there are plenty of bullish opportunities ahead for plugged-in investors...
by Greg Miller
I recently proclaimed 2019 the "year of CBD," and it seems from the mainstream coverage I'm starting to see, folks got the memo.
Early in 2018, Canopy Growth purchased Canadian hemp producer Green Hemp, and it also bought the assets of Ebbu LLC, a U.S.-based hemp company.
For 2019, Canopy is making even bigger moves in the cannabidiol market.
On Jan. 14, the Canadian company announced it received a license in New York to process and produce hemp. In what might be the largest hemp investment to date, Canopy will invest as much as $150 million in its New York operations to produce hemp extracts and hemp-based CBD products.
Not to be outdone, Aurora Cannabis is also getting in on the action.
In May 2018, Aurora boosted its stake in Hempco to more than 50%. For more than 10 years, Hempco has been a pioneer in hemp-based foods. A few months later, it acquired Europe's largest hemp producer, AgroPro.
In the next few months, Aurora will unveil a plan to produce hemp-derived CBD products for the U.S. market, according to Business Insider.
While this news is coming in at light speed, I can't say I was surprised; the passage of the Farm Bill effectively normalizes CBD across the country by making industrial hemp, a major source for CBD, legal on the federal level.
With these reforms, retailers nationwide can sell these products without fear of enforcement action by the government.
Last year was one of the best yet for marijuana stocks, but 2019 is shaping up to be the biggest year ever for cannabis.
In fact, 2019 will be the "year of CBD," and it could mean another huge year for cannabis stocks...
by Greg Miller
If you were following along, then you know that the entire marijuana sector had a pretty great 2018, Canada legalized cannabis at the national level, and California began sales of fully legalized weed for recreational use, to name a few.
But all this will pale in comparison to what's coming in 2019.
In fact, I believe one segment in particular will outperform everything we saw last year combined...
Marijuana stocks in 2019 are going to be the talk of Wall Street.
There will be huge profit opportunities in the marijuana sector.
The entire cannabis market could get a boost from this country...